2 results
Approved WMOCompleted
to determine the normal FGF23 response in case of hypophosphatemia
Not approvedWill not start
The primary objective is to investigate if there is an incremental inhibiting effect on MSNA by increasing dosage valsartan above the presently advised dosage. We hypothesize that there will be a further decrease in MSNA as compared to the MSNA…